Supramolecular gels obtained from organic low molecular mass (LMM) compounds find potential applications in various fields including biology, medicine, chemistry, and biological materials. 

We @ CLRI develop various supramolecular gels to understand the molecular mechanism of LMM self-assembly-induced gelation.

Our research interest also includes the development of supramolecular hydrogels and organogels using biomimetic LMM compounds for diverse applications, especially in drug delivery, cell proliferation, Anti-microbial activity, dye removal, etc.

Not only hydrogels and organogels, we are also interested in developing "ambidextrous gelators" using LMM compounds as they provide additional advantages in the arena of supramolecular gels.

In addition to supramolecular gels, our group is also interested in developing supramolecular hierarchical structures from amino acids and smaller peptide-based LMM compounds. 

Collagen is the most abundant fibrous protein in the extracellular matrix of our body. Under normal physiological conditions, homeostasis of tissue collagen is constantly maintained. But, during a number of pathological processes, collagens are over produced and accumulated. Such excess accumulation of collagens (referred to as fibrosis) is found to be the hallmark of many localized fibrotic diseases namely keloids, systemic scleroderma, atherosclerosis, and hypertrophic scars.

We @ CLRI searching for inhibitors of collagen fibrillation, a proposed to way to stop fibrosis, using biophysical techniques. 

In addition, we are also interested in understanding the interaction of various small molecules with collagen which is needed for the stabilization of collagen.